Dechra Pharmaceuticals (DPH)

 

Latest News

Total Voting Rights

RNS Number: 8673E Dechra Pharmaceuticals PLC 14 February 2018 14 February 2018 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Admission of Consideration Shares and Total Voting Rights Further to the announcement of the completion of the acquisition of AST Farma B.V. and Le Vet Beheer B.V. on 13 February 2018, ...

Completion of Acquisition

RNS Number: 7888E Dechra Pharmaceuticals PLC 13 February 2018 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, NEW ZEALAND...

Result of General Meeting - 12 February 2018

RNS Number: 5785E Dechra Pharmaceuticals PLC 12 February 2018 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, NEW ZEALAND...

Broker Forecast - Numis issues a broker note on Dechra Pharmaceuticals PLC

Numis today reaffirms its add investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and set its price target at 26...

All News

DateHeadlineSource
31-03-15Total Voting RightsRNS
16-03-15Block Listing Six Monthly ReturnRNS
16-03-15Holding(s) in CompanyRNS
27-02-15Total Voting RightsRNS
26-02-15City loves small-cap pharmaInteractive Investor
23-02-15Dechra Pharmaceuticals underlying operating profits up StockMarketWire
23-02-15Half Yearly Financial Report 2015RNS
23-02-15Dechra Pharmaceutical - Half year financial report 2015BRR Media
09-02-15How to value drug company management teamsInteractive Investor
30-01-15Total Voting RightsRNS
15-01-153 Fast-Growing Pharmaceuticals Set To Outperform: Shire PLC, BTG plc and Dechra Pharmaceuticals plcMotley Fool
14-01-15Dechra maintains momentum StockMarketWire
14-01-15Trading Update and Notice of HY resultsRNS
13-11-14Share Sleuth's November WatchlistMoney Observer
24-10-14Dechra in line with management expectationsStockMarketWire
15-09-14Dechra results bear out strategyRichard Beddard
08-09-14Dechra underlying pre-tax profits upStockMarketWire
08-09-14Dechra Pharmaceuticals - Preliminary Results for year ended 30 June 2014BRR Media
08-07-14Dechra in lineStockMarketWire
08-07-14Dechra revenues upStockMarketWire
20-05-14Dechra strengthens its US product portfolioStockMarketWire
02-05-14Dechra gets FDA and VMD approvalsStockMarketWire
30-04-14Dechra revenues upStockMarketWire
03-03-14Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
03-03-14Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
25-02-14Dechra underlying operating profits jumpStockMarketWire
29-01-14Dechra director leaves after board shake-upStockMarketWire
13-01-14Dechra operating profits in line with forecastsStockMarketWire
13-01-14Dechra on track despite weak NetherlandsStockMarketWire
08-01-14Four small-cap stocks for 2014 and beyond - part oneInteractive Investor
03-12-13Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
06-11-13Share Sleuth's November WatchlistMoney Observer
23-10-13Animalcare: enhancing medicines to enhance profitsRichard Beddard
22-10-13CVS, the veterinary group that does everythingRichard Beddard
18-10-13Dechra resolutions passed at AGMStockMarketWire
17-10-13Dechra SID retires StockMarketWire
17-10-13Dechra trading in line with forecastsStockMarketWire
07-10-13Dechra is animal pharmaceuticals pureplayRichard Beddard
03-09-13Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
03-09-13Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire

RSS feeds

  • Editorial news feed for LSE:DPH Editorial
  • Regulatory news feed for LSE:DPH Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account